The effect of a prostacyclin analogue (Iloprost) on skin temperature

J. K. Drury, J.J. Belch, M. McGregor, C. D. Forbes

    Research output: Contribution to journalArticle

    2 Citations (Scopus)

    Abstract

    Skin temperature was measured in the forearms of 8 healthy volunteers to study the effect of transdermal application of a stable prostacyclin analogue (Iloprost). Local skin temperature was significantly increased 24 hours and 48 hours after application of the drug when compared with an area of control skin. The effect had worn off by 72 hours. At a dose of 25 micrograms there were no systemic effects of vasodilatation or antiplatelet behaviour, but when the dose was increased to 75 micrograms there was a decreased rate of platelet aggregation for 24 hours. Histology of a skin biopsy suggested that the increase in skin temperature was due to vasodilatation and not acute inflammatory reaction. The results of this pilot study suggest that transdermal application of Iloprost is a suitable vehicle for administration of the drug and a prospective randomised trial is proposed for patients with Raynaud's Syndrome.
    Original languageEnglish
    Pages (from-to)301-303
    Number of pages3
    JournalProstaglandins,Leukotrienes and Medicine
    Volume19
    Issue number3
    DOIs
    Publication statusPublished - Sep 1985

    Fingerprint

    Iloprost
    Skin Temperature
    Epoprostenol
    Skin
    Vasodilation
    Platelet Aggregation
    Forearm
    Pharmaceutical Preparations
    Temperature
    Histology
    Healthy Volunteers
    Biopsy
    Platelets
    Agglomeration

    Cite this

    Drury, J. K. ; Belch, J.J. ; McGregor, M. ; Forbes, C. D. / The effect of a prostacyclin analogue (Iloprost) on skin temperature. In: Prostaglandins,Leukotrienes and Medicine. 1985 ; Vol. 19, No. 3. pp. 301-303.
    @article{64f0973bb24e4ef097f80645db5ebc6f,
    title = "The effect of a prostacyclin analogue (Iloprost) on skin temperature",
    abstract = "Skin temperature was measured in the forearms of 8 healthy volunteers to study the effect of transdermal application of a stable prostacyclin analogue (Iloprost). Local skin temperature was significantly increased 24 hours and 48 hours after application of the drug when compared with an area of control skin. The effect had worn off by 72 hours. At a dose of 25 micrograms there were no systemic effects of vasodilatation or antiplatelet behaviour, but when the dose was increased to 75 micrograms there was a decreased rate of platelet aggregation for 24 hours. Histology of a skin biopsy suggested that the increase in skin temperature was due to vasodilatation and not acute inflammatory reaction. The results of this pilot study suggest that transdermal application of Iloprost is a suitable vehicle for administration of the drug and a prospective randomised trial is proposed for patients with Raynaud's Syndrome.",
    author = "Drury, {J. K.} and J.J. Belch and M. McGregor and Forbes, {C. D.}",
    year = "1985",
    month = "9",
    doi = "10.1016/0262-1746(85)90143-X",
    language = "English",
    volume = "19",
    pages = "301--303",
    journal = "Prostaglandins,Leukotrienes and Medicine",
    issn = "0262-1746",
    publisher = "Churchill Livingstone",
    number = "3",

    }

    The effect of a prostacyclin analogue (Iloprost) on skin temperature. / Drury, J. K.; Belch, J.J.; McGregor, M.; Forbes, C. D.

    In: Prostaglandins,Leukotrienes and Medicine, Vol. 19, No. 3, 09.1985, p. 301-303.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - The effect of a prostacyclin analogue (Iloprost) on skin temperature

    AU - Drury, J. K.

    AU - Belch, J.J.

    AU - McGregor, M.

    AU - Forbes, C. D.

    PY - 1985/9

    Y1 - 1985/9

    N2 - Skin temperature was measured in the forearms of 8 healthy volunteers to study the effect of transdermal application of a stable prostacyclin analogue (Iloprost). Local skin temperature was significantly increased 24 hours and 48 hours after application of the drug when compared with an area of control skin. The effect had worn off by 72 hours. At a dose of 25 micrograms there were no systemic effects of vasodilatation or antiplatelet behaviour, but when the dose was increased to 75 micrograms there was a decreased rate of platelet aggregation for 24 hours. Histology of a skin biopsy suggested that the increase in skin temperature was due to vasodilatation and not acute inflammatory reaction. The results of this pilot study suggest that transdermal application of Iloprost is a suitable vehicle for administration of the drug and a prospective randomised trial is proposed for patients with Raynaud's Syndrome.

    AB - Skin temperature was measured in the forearms of 8 healthy volunteers to study the effect of transdermal application of a stable prostacyclin analogue (Iloprost). Local skin temperature was significantly increased 24 hours and 48 hours after application of the drug when compared with an area of control skin. The effect had worn off by 72 hours. At a dose of 25 micrograms there were no systemic effects of vasodilatation or antiplatelet behaviour, but when the dose was increased to 75 micrograms there was a decreased rate of platelet aggregation for 24 hours. Histology of a skin biopsy suggested that the increase in skin temperature was due to vasodilatation and not acute inflammatory reaction. The results of this pilot study suggest that transdermal application of Iloprost is a suitable vehicle for administration of the drug and a prospective randomised trial is proposed for patients with Raynaud's Syndrome.

    U2 - 10.1016/0262-1746(85)90143-X

    DO - 10.1016/0262-1746(85)90143-X

    M3 - Article

    C2 - 2414783

    VL - 19

    SP - 301

    EP - 303

    JO - Prostaglandins,Leukotrienes and Medicine

    JF - Prostaglandins,Leukotrienes and Medicine

    SN - 0262-1746

    IS - 3

    ER -